AMRUTANJAN HEALTH CARE LTD.-$ - 590006 - Announcement under Regulation 30 (LODR)-Investor Presentation
We wish to give the following additional information on the Q1 FY23 financial results published on 12th August, '22. Refer Our earlier announcement no: AHCL/ SE/ 19 /2022-23 dated 12/08/2022 Q1FY23 Quarterly Result Announced for Amrutanjan Health Care Ltd.
Pharmaceuticals firm Amrutanjan Health Care announced Q1FY23 Result : Key raw material prices excluding Menthol crystal price are higher when compared to Q1 FY22. The prices of packing materials are higher when compared to Q1 FY22. Advertisement spend for Q1 FY23 is at Rs.5.20 cr against Rs.4.28 cr for Q1 FY22. Advertisement spend for Comfy is at 3.90 cr for Q1 FY23 against 3.31 cr for Q1 FY22. Result PDF Amrutanjan reports lower net profit in Q122
Reports the quarter as perfect storm' as revenue falls AMRUTANJAN HEALTH CARE LTD.-$ - 590006 - Announcement under Regulation 30 (LODR)-Investor Presentation
Pursuant to Regulation 30 read with Para A of part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we hereby enclose the investor presentation for the quarter ended June 30, 2022 AMRUTANJAN HEALTH CARE LTD.-$ - 590006 - Announcement under Regulation 30 (LODR)-Change in Directorate
The Board of Directors at their meeting held today (August 12 2022) had inter alia considered and approved the following proposals 1. Re-appointment of Dr. Pasumarthi SN Murthi Non-Executive Director retiring my rotation subject to the approval of Shareholders. 2. Retirement of Dr. Mr. S. Vydeeswaran and Dr. Ms. Marie Shiranee Pereira Non-Executive Independent Directors of the Company at the ensuing Annual General Meeting. 3. Appointment of Ms. Meenalochani Raghunathan (DIN: 07145001) as an Additional Director (Non-Executive Independent) on the Board of the Company w.e.f 12.08.2022 subject to approval of shareholder in the 85th AGM. we further inform and declare that pursuant to Circular LIST/COMP /14/2018-19 dated June 20, 2018 . Ms. Meenalochani Raghunathan (DIN: 07145001) is not debarred from holding the office of Director by virtue of any SEBI order or any other such authority AMRUTANJAN HEALTH CARE LTD.-$ - 590006 - Book Closure
We wish to inform you that the Board of Directors of the Company at their meeting held today (Aug 12 2022) had inter-alia approved: a. Holding the Eighty Fifth (85th ) Annual General Meeting (AGM) of the Company on September 22, 2022 (Thursday) at 10.30A.M through Video Conference ('VC')/ Other Audio Visual Means ('OAVM') b. Thursday September 15, 2022 as the cut-off/Record date for the purpose of determining the eligibility criteria of shareholders to receive Final Dividend 2021-22 and to attend /vote at the Annual General Meeting to be held on September 22, 2022 c. The Book closure shall be from Friday, September 16, 2022 to Thursday, September 22, 2022 (both days inclusive) AMRUTANJAN HEALTH CARE LTD.-$ - 590006 - AGM Cut-Off Date- Book Closure- Regulation 42 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015(SEBI LODR)
We wish to inform you that the Board of Directors of the Company at their meeting held today (Aug 12 2022) had inter-alia approved: a. Holding the Eighty Fifth (85th ) Annual General Meeting (AGM) of the Company on September 22, 2022 (Thursday) at 10.30A.M through Video Conference ('VC')/ Other Audio Visual Means ('OAVM') b. Thursday September 15, 2022 as the cut-off/Record date for the purpose of determining the eligibility criteria of shareholders to receive Final Dividend 2021-22 and to attend /vote at the Annual General Meeting to be held on September 22, 2022 c. The Book closure shall be from Friday, September 16, 2022 to Thursday, September 22, 2022 (both days inclusive) AMRUTANJAN HEALTH CARE LTD.-$ - 590006 - Outcome Of The Board Meeting- Regulation 30 And 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 (SEBI LODR)
Pursuant to the subject regulation(s), we wish to inform that the Board of Directors of the Company at its meeting held today (August 12, 2022) had inter-alia approved the The Unaudited Financial Results for the quarter ended June 30, 2022 as recommended by the Audit Committee at its meeting held today (August 12, 2022). The same along with the Limited Review Report issued by M/s. B S R & Co. LLP, Statutory Auditors of the Company, is enclosed. Approved appointment of Ms. Meenalochani Raghunathan (DIN: 07145001) as an Additional Director (Non-Executive Independent) on the Board of the Company with effect from 12.08.2022 AMRUTANJAN HEALTH CARE LTD.-$ - 590006 - Board Meeting Outcome for Outcome Of The Board Meeting- Regulation 30 And 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 (SEBI LODR)
Pursuant to the subject regulation(s), we wish to inform that the Board of Directors of the Company at its meeting held today (August 12, 2022) had inter-alia approved the The Unaudited Financial Results for the quarter ended June 30, 2022 as recommended by the Audit Committee at its meeting held today (August 12, 2022). The same along with the Limited Review Report issued by M/s. B S R & Co. LLP, Statutory Auditors of the Company, is enclosed. Approved appointment of Ms. Meenalochani Raghunathan (DIN: 07145001) as an Additional Director (Non-Executive Independent) on the Board of the Company with effect from 12.08.2022 AMRUTANJAN HEALTH CARE LTD.-$ - 590006 - Board Meeting Intimation for Intimation Under Regulation 29 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 (SEBI LODR)
AMRUTANJAN HEALTH CARE LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2022 ,inter alia, to consider and approve Pursuant to the above mentioned regulation of SEBI LODR, we wish to inform that a meeting of the Board of Directors is scheduled to be held on Friday, the 12th August, 2022 thru Video Conferencing to consider and approve, inter-alia, the Un-Audited Financial Results along with the Limited Review Report for the quarter ended June 30 2022. It may also be noted that as already informed vide our letter dt. 29th June, 2022 , the Trading window for dealing in equity shares of the Company is closed effective from 1st July, 2022 and will remain closed till 14th August, 2022 pursuant to SEBI (PIT) Regulations, 2015 and in terms of Code of Conduct to regulate, monitor and report trading in securities of the Company. Request you to take the above on record and acknowledge.